Friday, September 4, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Earnings callNasdaq· January 16, 2026

Aehr Test (AEHR) Q2 2026 Earnings Call Transcript

View original at nasdaq.com
Aehr Test (AEHR) Q2 2026 Earnings Call Transcript Image source: The Motley Fool. DATE Thursday, January 8, 2026 at 5:00 p.m…
Opening lines of the source · Nasdaq · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Single AI processor wafer-level testing requires 20-30 systems at $4M-$5M each

    80% confidence
  • Testing and burning-in full wafers of GaN power semiconductors with up to 600 volts or more is not easy

    80% confidence
  • Lead Sonoma production customer provided very large forecast with shipments expected to start Q1 FY2027

    80% confidence
  • AI test and burn-in spending is currently $8B to $15B

    80% confidence
  • Aehr is not profitable at current revenue levels

    80% confidence
  • Aehr is the leading provider for HTOL testing of AI processors in test houses worldwide

    80% confidence
  • High Bandwidth Flash (HBF) development would take 1+ year after customer commitment

    80% confidence
  • Bookings forecast of $60M to $80M for second half FY2026 based on customer forecasts recently provided to Aehr

    80% confidence
  • The AI business opportunity for Aehr Test can be measured in hundreds of millions of dollars within a few years

    80% confidence
  • Aehr production capacity exceeds 20 systems per month at either package or wafer level, and can ship 20 per month of each if needed

    80% confidence
  • At least one customer is transitioning HTOL to production in late calendar 2026

    80% confidence
  • WaferPak design turnaround time is 8 weeks with Design for Test (DFT) lower pin count modes

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Funding Surge: Capital Floods Fintech, Foundation Models, and Autonomous Systems
A concentrated burst of AI-linked funding on 2026-08-28 pushed well over $1.5B into companies spanning fraud/identity fintech (Socure, which also acquired Fravity), foundation models (Stability AI), AI agents and enterprise tooling (Instinct, Generalist AI, Emerald AI, Owner), and AI-adjacent autonomous/aerospace ventures (Gatik, Regent Craft). The breadth and simultaneity of these rounds signal that investor appetite for AI is not concentrated in a single vertical but is broadening into applied and infrastructure-adjacent domains, with consolidation (Socure-Fravity) beginning alongside fresh capital formation.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,269 source documents archived
Query this data → isubstrate.com